Integrating Engineering, Manufacturing, and Regulatory Considerations in the Development of Novel Antivenoms

by Andreas Hougaard Laustsen, Netty Dorrestijn
Published 2018-07-01

Cost of Manufacturing for Recombinant Snakebite Antivenoms

by Timothy Patrick Jenkins, Andreas Hougaard Laustsen
Published 2020-07-01

Biosynthetic Oligoclonal Antivenom (BOA) for Snakebite and Next-Generation Treatments for Snakebite Victims

by R. Manjunatha Kini, Sachdev S. Sidhu, Andreas Hougaard Laustsen
Published 2018-12-01

Biotechnological Trends in Spider and Scorpion Antivenom Development

by Andreas Hougaard Laustsen, Mireia Solà, Emma Christine Jappe, Saioa Oscoz, Line Præst Lauridsen, Mikael Engmark
Published 2016-07-01

Editorial: Novel Immunotherapies Against Envenomings by Snakes and Other Venomous Animals

by Andreas Hougaard Laustsen, Stuart Ainsworth, Bruno Lomonte, R. Manjunatha Kini, R. Manjunatha Kini, Carlos Chávez-Olórtegui
Published 2020-05-01

Innovative Immunization Strategies for Antivenom Development

by Erick Bermúdez-Méndez, Albert Fuglsang-Madsen, Sofie Føns, Bruno Lomonte, José María Gutiérrez, Andreas Hougaard Laustsen
Published 2018-11-01

Toxin Neutralization Using Alternative Binding Proteins

by Timothy Patrick Jenkins, Thomas Fryer, Rasmus Ibsen Dehli, Jonas Arnold Jürgensen, Albert Fuglsang-Madsen, Sofie Føns, Andreas Hougaard Laustsen
Published 2019-01-01

Protease Activity Profiling of Snake Venoms Using High-Throughput Peptide Screening

by Konstantinos Kalogeropoulos, Andreas Frederik Treschow, Ulrich auf dem Keller, Teresa Escalante, Alexandra Rucavado, José María Gutiérrez, Andreas Hougaard Laustsen, Christopher T. Workman
Published 2019-03-01

Antibody Cross-Reactivity in Antivenom Research

by Line Ledsgaard, Timothy P. Jenkins, Kristian Davidsen, Kamille Elvstrøm Krause, Andrea Martos-Esteban, Mikael Engmark, Mikael Rørdam Andersen, Ole Lund, Andreas Hougaard Laustsen
Published 2018-09-01